Peroxisome proliferator-activated receptor gamma agonists in renal disease

European Journal of Endocrinology
Pedro Iglesias, Juan J Díez

Abstract

Type 2 diabetes is a well recognised cause of chronic renal failure (CRF). Only few oral antidiabetic drugs can be used for treating type 2 diabetes in patients with CRF. Among them are repaglinide, a rapid-acting prandial insulin releaser, and peroxisome proliferator-activated receptor gamma (PPARgamma) agonists, such as rosiglitazone and pioglitazone. These compounds are metabolised in the liver, therefore accumulation of the drug and the risk of severe and prolonged hypoglycaemia are minimised. PPARgamma receptors are expressed in many tissues including the kidney. Recently, numerous healthful effects of PPARgamma agonists on several aspects related to renal function have been increasingly reported. These drugs have shown to possess many advantageous anti-inflammatory, haemodynamic, vascular and metabolic effects. In the present paper we have reviewed the more recent experimental studies that evaluated these potential beneficial effects of PPARgamma agonists on renal function and revised the results of their utilisation in patients with different degrees of renal impairment, in dialysis patients, and in patients with diabetes mellitus after kidney transplantation. Finally, tolerability and safety profile of PPARgamma agonist...Continue Reading

Citations

Aug 3, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Agnes B Fogo
Oct 11, 2008·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Ying YaoGang Xu
Apr 26, 2012·Genes & Nutrition·Claudia Tovar-PalacioArmando R Tovar
Dec 29, 2009·Acta Pharmacologica Sinica·Rong ZouYing Yao
Aug 25, 2011·Genetic Testing and Molecular Biomarkers·Mehmet ErdoganCandeger Yilmaz
Apr 5, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gang Jee KoDae Ryong Cha
Feb 6, 2008·Diabetes, Obesity & Metabolism·Pedro Iglesias, Juan J Díez
Feb 4, 2011·American Journal of Physiology. Renal Physiology·Qing Qing WuChristopher Y Lu
Oct 15, 2009·Diabetology & Metabolic Syndrome·Themis ZelmanovitzLuís H Canani
Mar 7, 2013·Expert Opinion on Drug Metabolism & Toxicology·André J Scheen
Dec 21, 2007·Kidney International·S H ObligadoP J Nelson
Mar 19, 2008·Diabetes Research and Clinical Practice·Masanori AbeKoichi Matsumoto
Nov 21, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Olav A GressnerAxel M Gressner
Feb 14, 2014·Immunopharmacology and Immunotoxicology·Mohamed A IbrahimAly M Abdelrahman
Jun 15, 2015·International Immunopharmacology·Vengadeshprabhu KaruppagounderKenichi Watanabe
Jun 15, 2015·Journal of cardiology·Ekaterina A IvanovaAlexander N Orekhov
Jan 1, 2008·PPAR Research·Eva Kiss-Tóth, Tamás Roszer
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Sheila A Doggrell
Apr 26, 2011·The American Journal of Pathology·Chunhua ZhuAihua Zhang
Aug 4, 2016·The Journal of Pharmacy and Pharmacology·Devadoss J SamuvelMushfiquddin Khan
Feb 27, 2017·The Cochrane Database of Systematic Reviews·Clement LoSophia Zoungas
Jun 10, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Pilar SandovalManuel López-Cabrera
Dec 25, 2012·Journal of the American Society of Nephrology : JASN·Jun Chul KimJoel D Kopple
Jan 30, 2013·Nature Reviews. Nephrology·Colleen Flynn, George L Bakris
Feb 1, 2008·American Journal of Physiology. Renal Physiology·Xiongzhong RuanYoufei Guan
Nov 13, 2009·American Journal of Physiology. Renal Physiology·Ilaria MiceliGabriella Gruden
Dec 15, 2012·Pharmacological Reports : PR·Riham E MasoadHwayda S Abd El-All
Apr 26, 2016·Molecular Medicine Reports·Yao-Wu LiuXiao-Xing Yin
Jul 1, 2007·Expert Review of Endocrinology & Metabolism·Christof MayerMichael Stumvoll
Sep 1, 2007·Expert Review of Endocrinology & Metabolism·Hisashi Makino, Shin-Ichi Suga
Mar 12, 2020·International Journal of Nephrology·Yuhua MaJian Liu
Mar 9, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bihao LiuJiuyao Zhou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.